Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.45 USD | +0.09% |
|
-0.48% | -30.21% |
05-15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
05-14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.21% | 310M | |
+23.13% | 46.93B | |
+37.01% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+32.23% | 12.53B | |
-6.56% | 11.36B | |
-12.56% | 10.65B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- HC Wainwright Adjusts Korro Bio's Price Target to $115 From $100, Buy Rating Kept